[Effects of growth hormone on anthropometric and metabolic parameters in android obesity].

What Was Tested

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a randomized controlled trial.

The aim of the study was to evaluate the effect of GH on body weight, body composition and cardiovascular risk factors in android obese men.

Why It Was Studied

Bioimpedance analysis, DEXA, indirect calorimetry and cardiovascular risk factors were done at the beginning and at the end of the study.

Who Took Part

PubMed indexes the participants as adults and middle-aged adults, men only.

How the Study Was Run

The design is described as randomized, double-blind and placebo-controlled.

Because people in this Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Blinding on both sides kept the participants and researchers unaware of who received Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Some participants received a placebo instead of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), giving a reference point.

What Was Measured

Topics PubMed links to this paper include Absorptiometry, Photon, Body Composition, Calorimetry, Indirect, Electric Impedance, Human Growth Hormone, Intra-Abdominal Fat and Obesity.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

The publication is from 2006 (Arquivos brasileiros de endocrinologia e metabologia), a journal based in Brazil.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.